People · Operator
Named in public records as an officer, director or promoter · active 2007–2019 · Other, Other Technology, Retailing, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Metricstream Inc | — | Other | Series C | $174.3M | $428.6M | 2014 |
| Experticity, Inc. | — | Other | Series B | $29.5M | $223.6M | 2014 |
| Matchbin Inc | — | Other Technology | Series A | $22.0M | $207.3M | 2009 |
| High West Holdings, LLC | — | Retailing | Series A | $17.5M | $14.0M | 2007 |
| Peloton Interactive, Llc | — | Other | Series A | $16.1M | $30.3M | 2012 |
| Domain Surgical, Inc. | — | Other Health Care | Series A | $11.6M | $24.9M | 2011 |
| Molio, Inc. | — | Other Technology | Seed | $5.5M | $107.3M | 2014 |
| Zinch Inc | — | Other | Series A | $4.5M | $61.3M | 2009 |
| Overlay Studio, Inc. | — | Other Technology | Seed | $3.2M | $37.1M | 2014 |
| Ecomedes Inc. | — | Other Technology | Seed | $2.0M | $69.6M | 2019 |
Michael Levinthal at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Levinthal on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Scott Petty | 2 | 9 |
| Gavin Christensen | 1 | 23 |
| Lee Fixel | 1 | 20 |
| David Campbell | 1 | 12 |
| Dana Settle | 1 | 12 |
| David Heller | 1 | 10 |
| Sid Krommenhoek | 1 | 9 |
| Benjamin Levin | 1 | 9 |
| Timothy Connors | 1 | 7 |
| Michael Krupka | 1 | 7 |
| John Foley | 1 | 7 |
| Jeff Davis | 1 | 7 |
| Edward Gilhuly | 1 | 6 |
| Keith Daubenspeck | 1 | 4 |
| Wayne Cantwell | 1 | 4 |
| Frederic Mayerson | 1 | 4 |
| David McNally | 1 | 3 |
| Michael Hagen | 1 | 3 |
| Howard Draft | 1 | 3 |
| Blair Whitaker | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.